Expertos en Obesidad
Dr. Om Ganda
Graduated from the SMS Medical College, Jaipur, Rajasthan, India, and earned his MD (Medicine) at the AIIMS, New Delhi in 1970.
Dr. Ganda began his tenure at the Joslin Diabetes Center and the Harvard Medical School as a Research Fellow in 1973.
He is the Director of Lipid Center, Chair of the Joslin Clinical Guidelines Committee, senior faculty of Global Education and Care (GEC), and an Associate Professor of Medicine at the Harvard Medical School, Boston, MA
Dr. Francisco Javier Ampudia-Blasco
President of the Sociedad Española de Diabetes (SED), Section Chief of the Endocrinology and Nutrition Department at the University Clinical Hospital of Valencia and a Professor in the Department of Medicine at the University of Valencia. He also serves as a researcher at the CIBERDEM (Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Diseases).
Dr. Ampudia-Blasco earned his medical degree from the University of Valencia and completed his PhD at the Autonomous University of Barcelona. He specialized in Endocrinology and Nutrition at the Hospital de la Santa Creu i Sant Pau in Barcelona.
His primary research interests include diabetes management, insulin therapy, and continuous glucose monitoring systems. He has authored numerous scientific publications and has been involved in various national and international research projects. In April 2024, he was appointed President of the Spanish Diabetes Society (SED).
Jean Claude Mbanya
Professor of Medicine and Endocrinology at the Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Director Biotechnology Center and Postgraduate Dean Doctoral School of Life Sciences, Health and Environmental Sciences, University of Yaoundé 1. He is also Consultant Physician and Director of the National Obesity Centre at the University Teaching Hospital in Yaoundé. He is Honorary President of the International Diabetes Federation. His research interests are in the epidemiology of non-communicable diseases, especially diabetes and its complications, ethno-pharmacology and molecular biology of diabetes, hypertension, and thyroid diseases and their impact on the health care systems of developing countries. Output from his scientific research and service career has been published in 27 international book chapters and 190 papers indexed in peer-reviewed journals.
John Buse, MD, PhD
The Verne S. Caviness Distinguished Professor and Director of the Diabetes Center at the University of North Carolina (UNC) School of Medicine in Chapel Hill, North Carolina. He received his MD and PhD from Duke University before training in internal medicine and endocrinology at the University of Chicago. Dr. Buse completed service as President for Medicine & Science at the American Diabetes Association in 2008. He has received numerous awards and honors, including the 2010 Castle Connolly National Physician of the Year Award, the 2019 American Diabetes Association (ADA) Outstanding Achievement in Clinical Diabetes Research Award and the 2024 ADA Outstanding Physician Clinician in Diabetes Award. He has authored more than 500 publications. Dr Buse currently works with research teams in multicenter studies of diabetes and obesity treatment, in translating basic science innovation to clinical application, and in exploring the safety and efficacy of treatments using real world evidence.
Professor of Medicine, Mohamed Bin-Rashid
Based at Dubai. University, UAE, as well as senior consultant in Endocrinology and Diabetes at Dubai Hospital, Dubai, UAE since 2014. He also holds academic post as H Professor of Medicine, Gulf Medical University, UAE and past associate Director for Postgraduate Diabetes Education, Cardiff University, UK since 2007. He was appointed to the post of Consultant in the Department of Endocrinology and Diabetes at BCUHB, UK, in 2002. Dr Hassanein graduated from the Faculty of Medicine, Alexandria, Egypt.
His main research interest is in the field of diabetes and Ramadan. He co-authored recommendations papers on this subject for the American Diabetes Association (ADA) in 2005 and 2010, and for the British Medical Journal in 2010, Diabetes Canada in 2017 as well as the IDF-DAR practical guidelines, 2016 and 2021. Dr Hassanein has participated as the first author and/or a co-author in numerous studies and guidelines including studies on prevalence of diabetes, obesity, hypertension and is the first author for the Emirates Cardiometabolic guidelines. He has published over 110 papers. He’s also the associate editor of Dubai Diabetes and Endocrinology Journal.
Derechos de autor © 2026 Obesidad en México. Reservados todos los derechos.
